{"id":50125,"date":"2022-10-26T22:02:11","date_gmt":"2022-10-26T20:02:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/"},"modified":"2022-10-26T22:02:11","modified_gmt":"2022-10-26T20:02:11","slug":"global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/","title":{"rendered":"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644447\/global-smoking-cessation-clinical-trial-pipeline?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=spmcxj&amp;utm_campaign=1767596+-+Global+Smoking+Cessation+Clinical+Trial+Pipeline+Landscape+Report+2022&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Smoking Cessation Clinical Trial Pipeline Highlights &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221026006009\/en\/1615460\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221026006009\/en\/1615460\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe report provides the most up-to-date information on key pipeline products within the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials.\n<\/p>\n<p>\nThe pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.\n<\/p>\n<p>\n<strong>Clinical Trial Stages:<\/strong>\n<\/p>\n<p>\nThe report provides Smoking Cessation pipeline products by clinical trial stages including both early and late stage development &#8211; phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.\n<\/p>\n<p>\n<strong>Drug Mechanism Classes:<\/strong>\n<\/p>\n<p>\nThe report provides Smoking Cessation pipeline products by their dominant mechanism of action\/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.\n<\/p>\n<p>\n<strong>Company:<\/strong>\n<\/p>\n<p>\nThe report provides Smoking Cessation pipeline products by the company.\n<\/p>\n<p>\n<strong>Short-term Launch Highlights:<\/strong>\n<\/p>\n<p>\nFind out which Smoking Cessation pipeline products will be launched in the US and Ex-US till 2025.\n<\/p>\n<p>\n<strong>SUMMARY:<\/strong>\n<\/p>\n<ul>\n<li>\nSmoking Cessation phase 3 clinical trial pipeline products\n<\/li>\n<li>\nSmoking Cessation phase 2 clinical trial pipeline products\n<\/li>\n<li>\nSmoking Cessation phase 1 clinical trial pipeline products\n<\/li>\n<li>\nSmoking Cessation preclinical research pipeline products\n<\/li>\n<li>\nSmoking Cessation discovery stage pipeline products\n<\/li>\n<li>\nSmoking Cessation pipeline products short-term launch highlights\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644447\/global-smoking-cessation-clinical-trial-pipeline?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=spmcxj&amp;utm_campaign=1767596+-+Global+Smoking+Cessation+Clinical+Trial+Pipeline+Landscape+Report+2022&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/b95l4p<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;l&#x74;&#x6f;&#x3a;&#112;r&#x65;&#x73;&#x73;&#64;r&#x65;&#x73;&#x65;&#97;r&#x63;&#x68;&#x61;&#110;d&#x6d;&#x61;&#x72;&#107;e&#x74;&#x73;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#115;&#64;res&#x65;&#x61;&#x72;&#x63;&#104;&#97;ndm&#x61;&#x72;&#x6b;&#x65;&#116;&#115;&#46;co&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Smoking Cessation Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides the most up-to-date information on key pipeline products within the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials. The &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50125","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Smoking Cessation Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides the most up-to-date information on key pipeline products within the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials. The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-26T20:02:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221026006009\/en\/1615460\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-26T20:02:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/\"},\"wordCount\":292,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026006009\\\/en\\\/1615460\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/\",\"name\":\"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026006009\\\/en\\\/1615460\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-26T20:02:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026006009\\\/en\\\/1615460\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026006009\\\/en\\\/1615460\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Smoking Cessation Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides the most up-to-date information on key pipeline products within the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials. The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-26T20:02:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221026006009\/en\/1615460\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-10-26T20:02:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/"},"wordCount":292,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221026006009\/en\/1615460\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/","name":"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221026006009\/en\/1615460\/21\/logo.jpg","datePublished":"2022-10-26T20:02:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221026006009\/en\/1615460\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221026006009\/en\/1615460\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-smoking-cessation-clinical-trial-pipeline-landscape-report-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Smoking Cessation Clinical Trial Pipeline Landscape Report 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50125"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50125\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}